Obesity and Inflammatory Factors in the Progression of Early-Onset Colorectal Cancer
Cancers · 03.04.2024 · 16 (7) · 1403
DOI: 10.3390/cancers16071403 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 03.04.2024. Verfasst von Alexandra N Jones und 4 weiteren Autor:innen. Beteiligte Einrichtung: Price Institute of Surgical Research, University of Louisville, Louisville, KY 40202, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Barbara Thruston Atwood Price.
Abstract (Originalsprache)
Metabolic dysfunction associated with obesity leads to a chronic pro-inflammatory state with systemic effects, including the alteration of macrophage metabolism. Tumor-associated macrophages have been linked to the formation of cancer through the production of metabolites such as itaconate. Itaconate downregulates peroxisome proliferator-activated receptor gamma as a tumor-suppressing factor and upregulates anti-inflammatory cytokines in M2-like macrophages. Similarly, leptin and adiponectin also influence macrophage cytokine expression and contribute to the progression of colorectal cancer via changes in gene expression within the PI3K/AKT pathway. This pathway influences cell proliferation, differentiation, and tumorigenesis. This work provides a review of obesity-related hormones and inflammatory mechanisms leading to the development and progression of early-onset colorectal cancer (EOCRC). A literature search was performed using the PubMed and Cochrane databases to identify studies related to obesity and EOCRC, with keywords including ‘EOCRC’, ‘obesity’, ‘obesity-related hormones’, ‘itaconate’, ‘adiponectin’, ‘leptin’, ‘M2a macrophage’, and ‘microbiome’. With this concept of pro-inflammatory markers contributing to EOCRC, increased use of chemo-preventative agents such as aspirin may have a protective effect. Elucidating this association between obesity-related, hormone/cytokine-driven inflammatory effects with EOCRC may help lead to new therapeutic targets in preventing and treating EOCRC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Price Institute of Surgical Research, University of Louisville, Louisville, KY 40202, USA.
- Division of Colon and Rectal Surgery, Hiram C. Polk Jr. MD Department of Surgery, University of Louisville, Louisville, KY 40202, USA.
ORCID-Profile: Anne Macleod, Hillary L Simon, Susan Galandiuk
Förderung
- Barbara Thruston Atwood Price
Zitieren
APA
Jones, A. N., Scheurlen, K. M., Macleod, A., Simon, H. L., & Galandiuk, S. (2024). Obesity and Inflammatory Factors in the Progression of Early-Onset Colorectal Cancer. Cancers, 16(7), 1403. https://doi.org/10.3390/cancers16071403
Vancouver
Jones AN, Scheurlen KM, Macleod A, Simon HL, Galandiuk S. Obesity and Inflammatory Factors in the Progression of Early-Onset Colorectal Cancer. Cancers. 2024;16(7):1403. doi:10.3390/cancers16071403
BibTeX
@article{Jones2024,
author = {Jones, Alexandra N and Scheurlen, Katharina M and Macleod, Anne and Simon, Hillary L and Galandiuk, Susan},
title = {Obesity and Inflammatory Factors in the Progression of Early-Onset Colorectal Cancer},
journal = {Cancers},
year = {2024},
volume = {16},
number = {7},
pages = {1403},
doi = {10.3390/cancers16071403}
}
EUVIMED